Skip to content

Feasibility of a Deep Learning-based Algorithm for Non-invasive Assessment of Vulnerable Coronary Plaque

Not yet recruitingNCT06186336
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The primary objective of this study is to assess the accuracy in terms of sensitivity, specificity, negative and positive predicted values of the DL-based algorithm with respect to correct identification of the plaque and associated vulnerability grade.

Study details

Official title
Feasibility of a Deep Learning-based Algorithm for Non-invasive Assessment of Vulnerable Coronary Plaque
Conditions
Interventions
  • Other: Deep Learning-based Vulnerable Plaque Detection and Assessment Tool
Sponsor
GE Healthcare
Collaborators
Azienda Socio-Sanitaria Territoriale di Pavia
Start date
2025-01
Primary completion
2025-06
Sex
All
Results posted
No results posted in this snapshot
Countries
Italy
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Patients referred for a clinically indicated CCTA and ICA with OCT imaging examinations; 2. Diagnosis of chronic coronary syndrome, known CAD, or stable angina; AND, 3. Patients with ACS that may undergo a CCTA and not refer directly to the Cath lab for revascularization procedures. Exclusion Criteria: 1. Contradictions to contrast; 2. Contraindications for beta blocker; 3. BMI \>30; 4. High heart rate ≥75 BPM; 5. Atrial Fibrillation; 6. Arrythmia or irregular heartbeats; 7. Any prior coronary revascularization; 8. Presence of pacemaker or implantable cardioverter defibrillator; OR, 9. Patients with TAVI/TAVR.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06186336